News of Note—Cancer diagnostics startup Celcuity files for $15M IPO

News of note

> Cancer diagnostics startup Celcuity filed to raise up to $15 million in an IPO. The Minneapolis-based company is working on its CELx platform, which analyzes live tissue to pinpoint the specific abnormal activity that drives a patient’s cancer. Release

> The FDA cleared Titan Pharmaceuticals’ phase 1/2 clinical study of its ropinirole-delivering implant for the treatment of Parkinson’s disease. Release

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.